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T  cells exert both positive (helper)  and negative (suppressor) regulatory effects on 
antibody responses; these regulatory effects are the properties of unique subpopula- 
tions of T  cells  (1).  In many experimental systems involving active T  cell-mediated 
suppression, a soluble mediator responsible for observed effects has been demonstrated. 
These suppressor factors may be antigen-specific or nonspecific and their activity may 
or may not be restricted by products of the I-region of the major histocompatibility 
complex (1-4). 
We previously described a population of haplotype-specific suppressor T  (Ts) x cells 
that were activated by stimulating spleen cells from mice injected  as neonates with 
semiallogeneic  F:  spleen  cells  in  culture  with  macrophages  (Mq)) of the  allogeneic 
haplotype  encountered  as  neonates  (5).  The  Ts  cell  population  was  genetically 
restricted by I-A subregion products in its activation and action, and acted in a non- 
antigen-specific  manner  to  suppress  primary in  vitro  antibody  responses,  but  not 
secondary antibody responses or T  cell responses to alloantigens by syngeneic spleen 
cells. This communication demonstrates that these haplotype-specific Ts cells release 
a soluble factor (TsF-H) after stimulation by the appropriate Mq) that is responsible 
for the suppressive activity of these Ts cells; moreover, a T  cell hybridoma secreting 
monoclonal  TsF-H  has  been  developed.  TsF-H  from  these  two  sources  have  been 
compared by a variety of parameters described here and found to be identical. 
Materials and Methods 
The strains of mice used and their source, the source and preparation of antigen, the injection 
of neonatal B10 and BALB/c mice with (B10.D2 ×  B10)F1 spleen  cells to induce haplotype- 
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specific Ts cells,  culture  and  assay systems for plaque-forming cell  (PFC)  responses,  mixed 
lymphocyte reactions (MLR), and cytotoxic lymphocyte (CTL) responses have been described 
in detail in the accompanying manuscript (5). 
Preparation ofHaplotype-specific TsF-H.  Spleen cells  from control mice or B10 or BALB/c 
mice injected as neonates with (B10.D2 ×  B10)FI spleen cells were incubated at 5 ×  10  n cells/ 
well  with  3  ×  104 M~ of the appropriate  allogeneic haplotype in completely supplemented 
Eagle's minimal essential  medium with  10% fetal calf serum (lot 48006; Reheis Chemical Co., 
Kankakee, Ill.) in a final volume of 0.6 ml in 16-mm wells of a 24-multiwell tissue culture plate 
(76-033-05;  Linbro Division, Flow Laboratories, Inc., Hamden, Conn.) for 48 h under modified 
Mishell-Dutton conditions (6, 7). Culture supernates were collected, centrifuged at  1,500 rpm 
for 15 rain, filtered through 0.45-/z filters  (Millipore Corporation, Bedford, Mass.),  and stored 
at -70°C until use. 
Generation of T  Cell Hybridomas.  Spleen cells  (5  ×  10n/well)  from BI0 mice injected  with 
(B10.D2 ×  B10)F1 spleen cells as neonates were cultured with  3 ×  104 B10.D2-M4~ for 24 h 
under modified Mishell-Dutton  conditions  (6,  7).  These activated cells  were fused with  the 
hypoxanthine-guanine  phosphoribosyl transferase-deficient  AKR  thymoma, BW5147, using 
polyethylene glycol (8-I0). Cells were cultured in hypoxanthine-aminopterin-thymidine selec- 
tion medium  (8,  10,  11)  and scored for growth after 3-6 wk.  Cells  from primary wells  that 
yielded supernatant fluids that caused >75% suppression of PFC responses by B 10 spleen cells 
were cloned by limiting dilution  in soft agar over 3T3 feeder layers  (8,  10,  12). Individual 
colonies  were  plated  and  expanded,  and  supernatant  fluids  were  retested  for suppressive 
activity. The hybridoma to be discussed,  clone 267.A4.A1, has been maintained in tissue culture 
for >6 mo without loss of activity and active cells have been recovered after freezing in liquid 
nitrogen.  Supernatant  fluids from BW5147 alone and  from several wells  of the same fusion 
were  consistently  negative  for  TsF-H  activity  or  nonspecific  suppressor  activity.  Culture 
supernates from 267.A4.AI collected from cells grown to confluence were processed in the same 
way as described for conventional TsF-H containing supernatant  fluids.  Some culture super- 
nates or 267.A4.A1  supernates were concentrated  10 times by ultra filtration  using a  YM10 
filter  (Amicon  Corporation,  Lexington,  Mass.)  and  applied  to  a  Sephacryl  S-200  column 
equilibrated  with phosphate-buffered saline, pH 7.2. Fractions of 5.0 ml each were collected, 
filtered through 0.45-p filters,  and assayed for suppressive activity in the PFC assay. 
Antisera.  (B10.A  ×  B10) anti-B10.D2 (anti-KABJEa), [A.TL ×  B10.S  (9R)] anti-Bl0.HTT 
(anti-J~),  B10.A(5R) anti-B10.A(3R)  (anti-J~, and (B10.A  ×  A) anti-B10.A (5R)  (anti-KAB  b) 
antisera  were  the  generous  gift  of Dr.  D.  Shreffier  (Department  of Genetics,  Washington 
University School of Medicine, St. Louis, Mo.). (B 10.MBR × A/Sn) anti-B 10.A (5R)  (anti-A  b) 
was a gift of Dr. C. David (Mayo Medical School, Rochester, Minn.). A portion of the (B 10.A 
d  ×  B10)  anti-B10.D2  antisera  was absorbed  extensively on  the  H-2  mastocytoma P815  to 
remove all anti-K  a activity. Rabbit anti-mouse IgG was prepared as described by Theze et al. 
(13).  The  immunoglobulin  fractions  of the  heat-inactivated  antisera  were  used  to  prepare 
Sepharose immunoabsorbents. 
Results 
Demonstration  ofHaplotype-specific  TsF-H.  Spleen cells from neonatally treated  B10 
mice, containing haplotype-specific Ts cells, were cultured with Mq) of the appropriate 
and  inappropriate  haplotype  for  48  h;  the  culture  supernates  were  tested  for  the 
ability  to suppress  primary  in  vitro  PFC  responses  by syngeneic  spleen  cells  to  L- 
glutamic  acid6°-L-alaninea°-L-tyrosine 1°  (GAT)  and  sheep  erythrocytes  (SRBC).  Su- 
pernatant  fluids  from spleen cells restimulated  with  Mq~ of the allogeneic haplotype 
encountered  neonatally  (B10.D2)  profoundly suppressed  primary responses  to GAT 
and  SRBC  (Fig.  1).  Suppression was observed over a  substantial  range of dilutions; 
the  final  dilution  of  TsF-H  producing  50%  suppression  varied  with  individual 
preparations  of TsF-H, but was in the range of 1:500 to  1:1,000. TsF-H activity was 
not observed in culture fluids prepared from normal B 10 cells in an identical manner 
(data  not  shown)  or in supernates  of neonatally  treated  B10 spleen  cells stimulated 50  HAPLOTYPE-SPECIFIC  SUPPRESSOR  T  CELL FACTOR 
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Fie.  1.  Effects  of haplotype-specific TsF-H on primary PFC responses in vitro. Spleen cells (5 x 
108/culture) from BI0 mice injected as neonates with (B10.D2 X B10)FI spleen cells were cultured 
with 3 X 104 B10.D2 (A, I) or C3H (O, 0) M~ for 48 h. Culture supernatant fluids or 267.A4.A1 
hybridoma TsF-H fluids (A, UI) were harvested, filtered, and tested for suppressor activity at various 
dilutions in cultures of normal B10 spleen cells (5 X 10S/culture) stimulated with GAT or SRBC. 
IgG GAT-specific (k, A) or IgM SRBC (I, [7) PFC/culture  were determined on day 5; data are 
expressed as percent suppression of PFC response. Control supernatant  fluids failed to suppress 
either the GAT (0) or SRBC (O)  responses as did negative fusion wells (~). In the absence of 
TsF-H,  control  responses were 630 GAT-specific PFC/culture  and  5,094 PFC/culture  against 
SRBC. 
with C3H M~b. TsF-H derived from treated B 10 spleen cells had no effect on responses 
by BALB/c spleen cells to SRBC  (data not shown). No difference in cell number or 
in viability was observed in cultures with control or active TsF-H. The cell responsible 
for production of TsF-H was determined by stimulating different spleen cell popula- 
tions with the appropriate M~ and testing culture supernates for suppressive activity; 
only T  cells from lymph node or spleen, but not thymus, produced TsF-H  (data not 
shown).  These  findings  were  consistent  with  those  for Ts  cells  (5),  and  prompted 
attempts  to produce T  cell  hybridomas producing TsF-H by fusion of Ts cells with 
the thymoma line BW5147. Supernatant  fluids from the 27 wells positive for growth 
out of a  total of 60 wells plated were tested  for suppression of primary in vitro PFC 
responses.  The  eight  wells  showing  suppressive  activity  were  cloned  in  soft  agar, 
individual colonies were picked and grown in suspension culture, and supernates were 
retested for their ability to suppress primary PFC responses. Activity was demonstrated 
in  two  wells  of  the  24  that  gave  growth,  with  significant  suppression  in  clone 
267.A4.A1  seen  at  a  dilution  of  1:600,000  (Fig.  1).  Culture  supernates  from  the 
thymoma fusion partner, BW5147, failed to show suppression over the dilution ranges 
tested. 
Parameters of TsF-H Activity.  The ability of conventional and hybridoma TsF-H to 
suppress  primary  and  secondary  in  vitro  PFC  responses  MLR  and  CTL  responses 
were examined.  Significant  suppression  of primary  in  vitro  PFC  responses  to GAT 
and  SRBC  was  demonstrated  over  a  wide  range  of dilutions  of TsF-H  (Table  I); 
primary TNP-specific  PFC  responses  to TNP-SRBC  and TNP-Brucella  abortus were 
also  suppressed  (data  not  shown).  Similar  amounts  of TsF-H  failed  to  suppress 
secondary in vitro PFC responses (Table I) or MLR or CTL responses (Table II); this 
lack of antigen specificity and failure to suppress secondary PFC responses and MLR 
and  CTL  responses  were observed  with  the Ts cells  (5).  Analysis of the  kinetics  of 
suppression  showed that conventional or hybridoma TsF-H  must be present  during 
the first 36-48 h  of culture to achieve significant suppression  and that TsF-H added 
at culture initiation  blocked development of a significant PFC response (Fig. 2). CRAIG  M.  SORENSEN  AND  CARL  W.  PIERCE  51 
TABLE  I 
Effects of TsF-H on In  Vitro PFC Responses 
Responder B 10  Final dilution 
spleen cells  TsF-H 
Day 5 IgG PFC/ 
culture 
GAT  SRBC 
Experiment 1 
Experiment 2 
Virgin  None added  655  10,600 
Virgin  1:50  70  4,720 
Virgin  1:500  155  2,680 
GAT-immune  None added  603  5,880 
GAT-immune  1:50  555  2,660 
GAT-immune  1:500  615  1,750 
Virgin  None added  435  2,165 
Virgin  1,000  8  880 
Virgin  10,000  23  720 
GAT-immune  None added  620  ND* 
GAT-immune  1,000  600  ND 
GAT-immune  10,000  610  ND 
Spleen cells  (5 ×  10n/culture) from virgin B10 mice or BI0 mice immunized 4 wk 
earlier with 10 #g GAT in Maalox-pertussis were cultured with 2 #g GAT or  107 
SRBC and the indicated dilution of conventional H-2  b TsF-H in experiment 1 or 
267.A4.A1  H-2  b hybridoma TsF-H  in experiment  2.  Data  are  expressed  as  IgG 
GAT-specific PFC or primary IgM PFC vs. SRBC. 
* Not determined. 
TABLE  II 
Effects of TsF-H on CTL and MLR Responses 
CTL re- 
sponse 
assay*  MLR assay,  [all]-  Final dilution,  TdR incorporation  TsF-H  Specific  (~ SEM)~ 
51Cr 
release 
Experiment l  None added  77.5  7,621.5 (1.10) 
1:50  74.0  9,665.7  (1.04) 
1:100  76.3  8,466.3  (1.05) 
1:500  70.6  ND§ 
Experiment 2  None added  69.0  12,667.0 (1.05) 
1  : 100  70.2  11,881.0 (1.02) 
1 : 1,000  75.6  11,513.3  (1.05) 
* 7 ×  106 normal B10 spleen cells were cultured with 3 ×  106 irradiated (2,000 
rad) B10.D2 stimulator spleen cells and the indicated dilution of TsF-H. In 
experiment 1, conventional B 10-derived TsF-H were used; in experiment 2, 
H-2  ~ hybridoma TsF-H were used.  After 5 d, percent specific 51Cr release at 
an  effector  to  target  cell  ratio  of 20:1  on  P815  (H-2  a)  target  cells  was 
determined. Spontaneous release was 10%. 
* 200-#1 portions were removed at 72 h, pulsed with 1 #Ci [aH]TdR for 18 h, 
and harvested for [SH]TdR incorporation. 
§ Not determined. 
Genetic  Constraints on  TsF-H Production  and Activity.  Activation  of Ts cells and  their 
interaction with appropriate  target cells were highly genetically restricted by products 
of the I-A subregion of the H-2 complex  (5). A  similar analysis was made  with TsF-H. 
Spleen cells from  B10.D2  mice neonatally  treated  with  (B10.D2  ×  B10)F1 cells were 52  HAPLOTYPE-SPECIFIC SUPPRESSOR  T  CELL  FACTOR 
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FIo.  2.  Kinetics of TsF-H-mediated suppression. Bl0 spleen cells (5 X 106) were cultured with 10  7 
SRBC under Mishell-Dutton conditions.  Control fluid (A) conventional TsF-H (0)  (hl00 final 
dilution) or H-2  b hybridoma TsF-H, 267.A4.A1 (O)  (1:10,000 final dilution) was added at  the 
indicated time; IgM PFC/cuhure against SRBC were determined on day 5 (panel A). IgM PFC/ 
culture against SRBC were determined on the indicated days  in control (A) cultures or cultures 
receiving conventional TsF-H (hl00 final dilution) (O) or H-2  b hybridoma TsF-H, 267.A4.A1 ((9) 
on day 0 (panel B). 
TABLE III 
Genetic Requirements  for Production of TsF-H 
Day 5 
Source of  GAT- 
TsF-H*  Stimulating M#  Shared H-2 regionsqk  specific 
PFC/ 
culture§ 
Experiment 1  B10.D2 
Experiment 2  B 10 
None  None  633 
B10.A (3R)  KABJ  95 
B10.A (5R)  KAB  13 
B10.A (4R)  BJE  603 
None  None  570 
B 10.D2  KABJECSGD  70 
B 10.GD  KA  100 
B 10.LG  K  603 
* Spleen cells (5 X l0  t') from B10.D2 mice (experiment  1) or from BI0 mice (experiment  2) 
neonatally treated with (B10.D2 ×  B10)F1 cells were incubated 48 h with 3 X 104 M~b of 
the indicated haplotype. Supernatant fluids were harvested  and tested for TsF-H activity. 
:1:H-2 regions shared between the stimulating Md~ and the allogeneic haplotype encountered 
neonatally. 
§ Normal B10.D2 spleen cells (experiment  1) or B10 spleen cells (experiment  2)  (5 X  106) 
were cultured with 2 #g GAT and TsF-H (1:500 final dilution) under Mishell-Dutton 
conditions; IgG GAT-specific PFC/cuhure were determined on day 5. 
stimulated with  a  panel of M~b and TsF-H  activity was  determined;  M~  from  B10, 
B 10.A(3R), and B 10.A(5R)  stimulated production of TsF-H, whereas B 10.A(4R)  Mq~ 
failed to stimulate TsF-H  production  (Table III). Using spleen cells from  B10  mice 
neonatally treated  with  (B10.D2  ×  B10)F1 cells, B10.D2  and B10.GD  M~ stimulate 
TsF-H  production,  whereas  B10.LG  M4~  failed  to  stimulate  TsF-H  production, 
demonstrating that syngenicity at the I-A subregion of the H-2 complex between the 
stimulator Mff and the allogeneic haplotype used to treat neonates was necessary and 
sufficient. 
Genetic  restrictions  on  the  activity  of TsF-H  were  investigated  using responder 
spleen cells  from  mice sharing various regions of the  H-2 complex with  the TsF-H- 
producing cells. Significant suppression was observed only when the TsF-H-producing 
cell and the responder target  spleen cells shared  an identity at  the I-A subregion of CRAIG M.  SORENSEN  AND CARL W.  PIERCE  53 
the H-2 complex (Table IV). This was demonstrated  by the ability of B10 TsF-H to 
suppress primary responses by B10, B10.A(3R),  and B10.A(5R)  spleen cells, but not 
B 10.A(4R) spleen cells  (this does not exclude the requirement  for identity at K) and 
BALB/c TsF-H  to suppress  PFC responses by B10.GD but  not B10.LG spleen cells. 
An interesting point was the lack of a requirement  for syngenicity at the I-J subregion 
between the TsF-H-producing cell and its target population identity, which is required 
in some other suppressor systems (3, 4). 
Characterization  of Conventional and Hybridoma  TsF-H 
MOLECULAR WEIGHT DETERMINATION,  The relative molecular weight of TsF-H was 
determined  by gel filtration  through a  Sephacryl S-200 column. TsF-H activity was 
recovered  in  fractions  collected  between  the  bovine  serum  albumin  (BSA)  and 
ovalbumin  (OVA)  markers,  placing the  apparent  molecular weight  in  the  range of 
45,000 to 68,000 (Fig. 3). 
SENSITIVITY TO  HEAT, pa,  AND TRYPSIN.  The  stability  of TsF-H  under  different 
temperatures,  pH,  and  treatment  with  trypsin  was examined  (Table  V).  Biological 
activity was  destroyed  at  60°C  (partially  at  40°C)  for 30  min,  by pH  3.5,  and  by 
treatment with trypsin, which suggests that TsF-H is a  protein and that some degree 
of tertiary structure was required for activity. 
PRESENCE  OF  Ig  OR  H-2  COMPLEX DETERMINANTS.  TsF-H  was  analyzed  for  the 
presence of serologically detectable Ig or H-2 complex determinants  by the ability of 
immunoabsorbents of alloantisera specific for subregions of the H-2 complex to absorb 
out  suppressor  activity.  BALB/c  TsF-H  could  be  absorbed  by  and  eluted  from  a 
(B10.A  x  B10)  anti-B10.D2,  anti-(KABJE) d  immunoabsorbent,  but  failed  to  be 
TABLE IV 
Genetic Restrictions of TsF-H Activity on Target Cells 
Responder  Source of  Shared H-2 
spleen cells  TsF-H  regions* 
Day 5 PFC/ 
culture:]: 
GAT  SRBC 
B10  None  None  413  5,350 
B 10  B 10  KABJECSGD  15  200 
B10.A (3R)  B10  KABJ  <10  428 
B10.A (3R)  267.A4.A1  KABJ  <10  380 
B10.A (5R)  B10  KAB  10  325 
B10.A (5R)  267.A4.A1  KAB  <10  375 
B10.A (4R)  B10  BJECSGD  653  5,296 
B10.A (4R)  267.A4.A  1  BJECSGD  450  5,150 
BI0.D2  None  None  461  ND§ 
B10.D2  BALB/c  KABJECSGD  <10  ND 
B10.GD  BALB/c  KA  <10  ND 
B10.LG  BALB/c  K  405  ND 
* H-2 regions shared between the cells producing TsF-H and the responder 
spleen cells. 
5 x  106 responder spleen cells of the indicated strains were cultured with 2 
#g GAT or SRBC (107), conventional TsF-H (1:500 final dilution), and H-2  b 
hybridoma TsF-H, and 267.A4.A1 (1:60,000 final dilution) under Mishell- 
Dutton  conditions; IgG-GAT-specific  or IgM vs. SRBC PFC/culture  were 
determined on day 5. 
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FIe.  3.  Apparent molecular weight determination of TsF-H by gel filtration. BALB/c conventional 
TsF-H (O)  or hybridoma TsF-H, 267.A4.A1, (O) were concentrated  10 times by ultra-filtration on 
an Amicon YM-10 filter before chromatography on a Sephacryl S-200 column. Approximately 5.0- 
ml fractions were collected and assayed for activity by their ability to suppress a  primary in vitro 
response to GAT by BALB/c spleen cells cultured under Mishell-Dutton conditions. Arrows indicate 
the fractions where the marker proteins eluted. OD at 280 nm (A). 
TABL~  V 
Partial Characterization of TsF-H 
Treatment of TsF-H 
Day 5 GAT-specific PFC/culture 
Conventional  Hyhridoma TsF-H 
TsF-H  267.A4.A 1 
None  420  310 
None  55  25 
pH 3.5  403  290 
60°C, 30 min  513  326 
Trypsin  345  300 
None  840  330 
None  43  <10 
40°C, 30 min  40  13 
50°C, 30 min  345  168 
60°C, 30 min  813  326 
5 X  l0  s B10 spleen cells were cultured with 2/~g GAT and conventional TsF- 
H  (1 : 100 final dilution) or hybridoma TsF-H 267.A4.A1 (1:6,000 final dilution) 
treated  as shown under Mishell-Dutton conditions;  IgG GAT-specific PFC/ 
culture were determined on day 5. 
absorbed by a  (B10.A  X A)  anti-B10.A  (5R), anti-(KAB) b immunoabsorbent  (Table 
VI), suggesting the presence of H-2 complex determinants on TsF-H.  The (B10.A  X 
B10)  anti-B10.D2  antisera extensively absorbed with the H-2  d mastocytoma P815 to 
remove all anti-K  d activity was still able to remove suppressor activity, which suggests 
the presence of I-region determinants on the factor. The identification of the subregion 
involved was made using B10-derived TsF-H. The H-2 b factor could be absorbed by 
and  eluted  from  a  (B10.A  X  A)  anti-B10.A  (SR),  anti-(KAB) b,  or a  (B10.MBR  X 
A/Sn)  anti-B10.A  (5R), anti-(A) b immunoabsorbent, but failed to be absorbed by a 
B10.A  (5R),  anti-B10.A(3R),  anti-(Jb),  or  the  (B10.A  X  B10)  anti-B10.D2  immu- 
noabsorbent  previously  shown  to  remove the  H-2 d TsF-H  (Table  VI).  The  anti-J b 
immunoabsorbent was shown to be functional by the ability to remove a GT-specific CRAIG  M.  SORENSEN  AND  CARL  W.  PIERCE  55 
TABLE  VI 
Partial Immunochemical Characterization of Conventional and Monoclonal 
TsF-H 
TsF-H source*  Immunoabsorbent 
Suppression of day 5 
GAT-specific PFC 
response 
Effluent:[:  Eluate:~ 
BALB/c  None 
BALB/c  aIg  88 
BALB/c  a(KABJE) a  0 
BALB/c  ~(KABJ)  dabs P815§  8 
BALB/c  a(KAB)  b  70 
BALB/c  aA  b  90 
B 10  None 
B 10  aIg  80 
B 10  a(KAB)  b  12 
B 10  aA  b  0 
B10  ~tJ  b  94 
B10  aJ  8  93 
B10  a(KABJE) d  88 
B10  ot(KABJ)  dabs P815  86 
267.A4.A 1  None 
267.A4.A 1  aIg  90 
267.A4.A1  ot(KAB) b  0 
267.A4.A1  otA  b  0 
267.A4.A1  t~J  b  90 
267.A4.A 1  a(KABJE) d  91 
90 
92 
84 
8 
92 
86 
12 
0 
10 
98 
86 
6 
7 
2 
5 
11 
85 
95 
12 
10 
* Normal BALB/c or B10 spleen cells (5 ×  106) were cultured with 2 gg GAT 
and  the  conventional  TsF-H  (l:100  final  dilution)  or  hybridoma  TsF-H 
267.A4.A1 (1:600 final dilution) under Mishell-Dutton conditions; IgG GAT- 
specific  PFC/culture  were  determined  on  day  5.  Data  are  presented  as 
percent suppression of control responses. 
:~ Effluents  from  the  immunoabsorbents were  tested  directly;  eluates  were 
recovered with 2.0 M  KCI and dialyzed before assay. 
§ Antiserum was extensively absorbed on P815 to remove anti-K  d activity. No 
further  activity  was  demonstrated  by  microcytotoxicity  analysis on P815 
cells. 
suppressor factor of the appropriate specificity (J.  Kapp, personal communication). 
Rabbit anti-mouse Ig or rabbit anti-mouse Fab reagents failed to absorb either B10 
or BALB/c TsF-H. These results strongly suggest that TsF-H does not bear classical 
immunoglobulin constant-region determinants, but does bear determinants encoded 
by the I-A subregion of the H-2 complex. 
Discussion 
Suppressive activity has  been demonstrated  in  supernatant  fluids of spleen Cells 
from mice treated as neonates with semiallogeneic F1 spleen cells cultured with M~ of 
the allogeneic H-2 haplotype encountered as neonates. Production of TsF-H required 
T  cells (lymph node or spleen, but not thymus)  from mice treated as neonates and 
M(h syngeneic at  the I-A subregion of H-2 with the allogeneic partner used  in  the 
neonatal treatment. TsF-H suppressed only primary in vitro antibody responses by 
spleen cells from mice sharing identity at the I-A subregion with the mice producing 56  HAPLOTYPE-SPECIFIC SUPPRESSOR T  CELL FACTOR 
TsF-H. In vivo activity of TsF-H is currently being tested. TsF-H, although restricted 
genetically with  respect  to  production  and  interaction with  target  cells,  was  non- 
antigen-specific  and  suppressed  responses  to  both  T  cell-dependent  and  T  cell- 
independent  antigens.  TsF-H  failed to suppress  secondary antibody responses  and 
MLR or CTL responses. TsF-H is a protein with a molecular weight in the range of 
45,000-68,000 that bears determinants of the I-A subregion of the H-2 complex but 
not  demonstrable Ig constant-region determinants.  A  T  cell hybridoma producing 
monoclonal TsF-H  with  identical  activities  and  properties  has  been  produced  by 
fusion of the AKR thymoma BW5147 with T  cells from B10 mice treated as neonates 
with (B10.D2 ×  B10)F1 cells (8). 
Numerous examples of Ts cells and soluble suppressor molecules that mediate their 
effects have been reported (3, 4,  14-18); these diverse systems have been compared, 
contrasted, and integrated by Germain and Benacerraf (14). The suppressor pathway 
is  initiated  by the  interaction of antigen  with  antigen-specific Ly-1  +  or  Ly-l,2,3  + 
(frequently I-J  +) Ts cells that produce suppressor factors (TsF1)  that act across H-2 
and VH differences. These factors are proteins with molecular weights of ~50,000 that 
bind antigen, bear I-J determinants, and, where tested, bear the appropriate idiotype 
of the system. These TsF1 appear to induce together with antigen a second set of Ts 
cells  (Ts~ cells)  that  are  Ly-l,2,3  +,  I-J  +,  and  either  antigen-specific or specific for 
idiotype (i.e.,  anti-idiotypic). These cells or a succeeding set of Ly-2,3  +, I-J  + effector 
Ts cells  produce suppressor  factors  (TsF2)  whose  activity is  restricted  by H-2  (I-J 
subregion) and, for anti-idiotypic Ts2, VH-linked genes. These TsF2 are also proteins 
with a  molecular weight of ~50,000 that  are I-J  + and bear receptors for antigen or 
idiotype in  cases where activity is  restricted by VH-linked genes.  Finally,  antigen- 
primed Ly-1,2,3  +, I-J  +, idiotype-positive Ts3 cells after appropriate activation produce 
nonspecific suppressor factors that appear ultimatelyto mediate suppression. Impor- 
tant  distinctions exist between these various antigen-specific suppressor factors and 
the haplotype-specific suppressor factor described here apart from the lack of antigen 
specificity. The antigen-specific suppressor factors described to date bear determinants 
encoded by the I-J  (in one case I-C)  subregion of the H-2 gene complex (3, 4,  14). 
Tada (3,  19) reports a strict requirement for syngenicity at I-J between a TsF2 and its 
target cell, whereas Kapp  (20)  demonstrated the presence of I  region determinants 
(presumably I-J determinants) on the GAT-TsF, most likely a TsF1, but showed that 
GAT-TsF from nonresponders can  cross-suppress  responses  by other nonresponder 
cells (3, 14). Other suppressor factors in the GT system (4, 14), the feedback suppressor 
pathway in responses to SRBC (14,  15), and delayed hypersensitivity to the azoben- 
zenearsonate and 4-hydroxy-3-nitrophenyl acetate systems (4, 14, 17), are presumably 
in the TsF1 class, and are I-J  + and not H-2-restricted. A suppressor factor involved in 
contact  hypersensitivity  responses  bears  I-C  subregion  products  and  is 
H-2-restricted and  is therefore in the TsF2 class  (14,  16).  In contrast, we have been 
unable to demonstrate I-J determinants on TsF-H or a restriction in TsF-H activity 
by the I-J subregion. Instead, TsF-H activity is restricted by the I-A subregion and 
I-A determinants are present on TsF-H. This same lack of involvement of I-J, and 
restriction by products of the I-A subregion was observed with the haplotype-specific 
Ts cell itself (5). These findings and others bring into question the actual role, if any, 
of I-J determinants in suppression. One possibility is that the I-J subregion encodes 
more than one product, and that  distinct I-J products are expressed by the various CRAIG  M.  SORENSEN  AND  CARL  W.  PIERCE  57 
precursor, inducer, and effector cells in the helper-suppressor T  cell circuits (3, 14, 21, 
22; D. Murphy, personal communication). The existence of distinct I-J products on 
these  ceils could  be the  basis  for their interrelationship  and  communication.  The 
presence of I-J determinants on the haplotype-specific Ts cell has not been ruled out; 
studies  to date have only shown that  the I-J subregion does not  restrict either the 
suppressor ceils or TsF-H. Studies are in progress to determine the surface phenotype 
of these suppressor cells and to examine the possibility that  I-J determinants other 
than those classically expressed on Ts cells  (3,  4,  14,  19,  22;  D.  Murphy, personal 
communication) are expressed on the cells or the factor. 
The haplotype-specific Ts cell-TsF-H system  has  more similarities  to  the  MLR 
suppressor system of Rich and Rich (23-25) than to the antigen-specific systems. This 
system is activated after exposure to alloantigens in vivo and restimulation in vitro; 
activated Ts cells are short-lived cells that act via a factor MLR-TsF that suppresses 
the MLR in a  genetically restricted but non-antigen-specific manner (24, 25).  Syn- 
genicity at I-J between factor and target cell for expression of MLR-TsF activity is 
not  required;  instead,  syngenicity at  the  I-E/C  subregion of H-2  is  necessary and 
sufficient. It is interesting to speculate about why suppressor systems in response to I- 
subregion-encoded determinants appear to have regulatory or genetic constraints that 
differ from Ts ceils that are stimulated by conventional antigens. Suppressor systems 
involving conventional antigens are intimately associated with I-J subregion regula- 
tion, whereas the haplotype-specific and MLR Ts systems do not appear to involve 
the  I-J  subregion,  but  are  regulated  by I-A and/or  I-E/C  subregions.  The  major 
exception, the contact hypersensitivity suppressor system (16) is regulated by the I-C 
subregion. However, this system and the suppressor systems involving delayed hyper- 
sensitivity to azobenzenearsonate and 4-hydroxy-3-nitrophenyl acetate are activated 
by presenting  the  relevant  determinant  to  the  immune  system  on  lymphoid  cells 
whose I-region products may be modified by these determinants  (14). Thus,  these 
hypersensitivity suppressor systems and the MLR and haplotype-specific suppressor 
systems are examples of Ts systems  that,  because of the critical  involvement of I- 
region  products  in  their  activation,  may  not  be  regulated  by  the  I-J  subregion. 
Regulation of suppressor systems involving conventional antigens, which may or may 
not  be  presented  in  the  context  of I-region  products,  but  which  do  not  involve 
responses  to  I-region  products  or  modified  I-region  products,  may  be  regulated 
exclusively by I-J subregion products. Further data that should be forthcoming from 
several laboratories should answer these questions. 
Further, studies on the biochemical nature, structure, and mechanism of the action 
of TsF-H  will  be  facilitated  by  the  availability  of T  cell  hybridomas  producing 
monoclonal TsF-H. Preliminary studies indicate that TsF-H induces another popu- 
lation of T  cells to produce a  second factor that acts in a  non-antigen-specific, non- 
MHC-restricted fashion to inhibit antibody responses. Characterization of these cells 
and their factor is in progress. 
Summary 
Culture  supernatant  fluids  from  spleen  cells  from  C57BL/10  or  BALB/c  mice 
neonatally treated with semiallogeneic (B10.D2 ×  B10)FI cells to induce haplotype- 
specific suppressor T  cells and restimulated with macrophages syngeneic at I-A with 
the allogeneic haplotype encountered as neonates contain a soluble factor capable of 58  HAPLOTYPE-SPECIFIC SUPPRESSOR T  CELL FACTOR 
suppressing primary in vitro antibody responses of normal syngeneic spleen cells in a 
non-antigen-specific  manner.  This haplotype-specific suppressor factor, TsF-H, has 
also been recovered in culture fluids of a T  cell hybridoma produced by fusion of the 
AKR  thymoma  BW5147  and  the  haplotype-specific  suppressor  T  cells.  TsF-H  is 
inactivated by low pH (3.5)  trypsin, for 30 min at 50°C, and has a molecular weight 
in the range of 45,000 to 68,000. Studies with specific immunoabsorbents demonstrate 
the presence of determinants encoded by the I-A subregion of the haplotype of the T 
cell  producing  TsF-H  but  not  I-J  subregion  or  immunoglobulin  constant-region 
determinants  on  the  TsF-H.  Suppression  is  restricted  to primary in  vitro antibody 
responses, and not secondary antibody, mixed lymphocyte, or cytotoxic lymphocyte 
responses  by  spleen  cells  syngeneic  at  the  I-A subregion  of H-2  with  the  T  cell 
producing  the  factor.  The  properties  and  activities  of TsF-H  and  the  haplotype- 
specific  suppressor  T  cell  are  compared  and  contrasted  with  antigen-specific  and 
genetically restricted suppressor T  cells and their factors. 
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